Bif-1 haploinsufficiency promotes chromosomal instability and accelerates Myc-driven lymphomagenesis via suppression of mitophagy.

Malignant transformation by oncogenes requires additional genetic/epigenetic changes to overcome enhanced susceptibility to apoptosis. In the present study, we report that Bif-1 (Sh3glb1), a gene encoding a membrane curvature–driving endophilin protein, is a haploinsufficient tumor suppressor that plays a key role in the prevention of chromosomal instability and suppresses the acquisition of apoptosis resistance during Myc-driven lymphomagenesis. Although a large portion of Bif-1–deficient mice harboring an Eμ-Myc transgene displayed embryonic lethality, allelic loss of Bif-1 dramatically accelerated the onset of Myc-induced lymphoma. At the premalignant stage, hemizygous deletion of Bif-1 resulted in an increase in mitochondrial mass, accumulation of DNA damage, and up-regulation of the antiapoptotic protein Mcl-1. Consistently, allelic loss of Bif-1 suppressed the activation of caspase-3 in Myc-induced lymphoma cells. Moreover, we found that Bif-1 is indispensable for the autophagy-dependent clearance of damaged mitochondria (mitophagy), because loss of Bif-1 resulted in the accumulation of endoplasmic reticulum–associated immature autophagosomes and suppressed the maturation of autophagosomes. The results of the present study indicate that Bif-1 haploinsufficiency attenuates mitophagy and results in the promotion of chromosomal instability, which enables tumor cells to efficiently bypass the oncogenic/metabolic pressures for apoptosis. .

[1]  Jeremy M. Stark,et al.  A dual role for UVRAG in maintaining chromosomal stability independent of autophagy. , 2012, Developmental cell.

[2]  P. Atadja,et al.  Combination of Pan-Histone Deacetylase Inhibitor and Autophagy Inhibitor Exerts Superior Efficacy against Triple-Negative Human Breast Cancer Cells , 2012, Molecular Cancer Therapeutics.

[3]  D. Green,et al.  Mitochondrial dysfunction in ataxia-telangiectasia. , 2012, Blood.

[4]  N. Mizushima,et al.  The role of Atg proteins in autophagosome formation. , 2011, Annual review of cell and developmental biology.

[5]  A. Strasser,et al.  Deciphering the rules of programmed cell death to improve therapy of cancer and other diseases , 2011, The EMBO journal.

[6]  N. Ip,et al.  Cdk5-mediated phosphorylation of endophilin B1 is required for induced autophagy in models of Parkinson's disease , 2011, Nature Cell Biology.

[7]  D. Coppola,et al.  Down-Regulation of Bax-Interacting Factor 1 in Human Pancreatic Ductal Adenocarcinoma , 2011, Pancreas.

[8]  N. Mizushima,et al.  Parkin Mediates Proteasome-dependent Protein Degradation and Rupture of the Outer Mitochondrial Membrane*♦ , 2011, The Journal of Biological Chemistry.

[9]  H. Coller,et al.  Activated Ras requires autophagy to maintain oxidative metabolism and tumorigenesis. , 2011, Genes & development.

[10]  Sonja Hess,et al.  Broad activation of the ubiquitin–proteasome system by Parkin is critical for mitophagy , 2011, Human molecular genetics.

[11]  Hong-Gang Wang,et al.  Bif-1 regulates Atg9 trafficking by mediating the fission of Golgi membranes during autophagy , 2011, Autophagy.

[12]  R. Youle,et al.  Proteasome and p97 mediate mitophagy and degradation of mitofusins induced by Parkin , 2010, The Journal of cell biology.

[13]  C. Scott,et al.  Elevated Mcl-1 perturbs lymphopoiesis, promotes transformation of hematopoietic stem/progenitor cells, and enhances drug resistance. , 2010, Blood.

[14]  Derek Y. Chiang,et al.  The landscape of somatic copy-number alteration across human cancers , 2010, Nature.

[15]  T. Noda,et al.  A subdomain of the endoplasmic reticulum forms a cradle for autophagosome formation , 2009, Nature Cell Biology.

[16]  Eeva-Liisa Eskelinen,et al.  3D tomography reveals connections between the phagophore and endoplasmic reticulum , 2009, Autophagy.

[17]  E. White,et al.  The Double-Edged Sword of Autophagy Modulation in Cancer , 2009, Clinical Cancer Research.

[18]  Y. Takahashi,et al.  Bif-1/Endophilin B1: a candidate for crescent driving force in autophagy , 2009, Cell Death and Differentiation.

[19]  R. Youle,et al.  Parkin is recruited selectively to impaired mitochondria and promotes their autophagy , 2008, The Journal of cell biology.

[20]  T. Yeatman,et al.  Down‐regulation of Bax‐interacting factor‐1 in colorectal adenocarcinoma , 2008, Cancer.

[21]  N. Yoo,et al.  Decreased expression of Bax‐interacting factor‐1 (Bif‐1) in invasive urinary bladder and gallbladder cancers , 2008, Pathology.

[22]  J. Pow-Sang,et al.  Bax-interacting factor-1 expression in prostate cancer. , 2008, Clinical genitourinary cancer.

[23]  Jae U. Jung,et al.  Beclin1-binding UVRAG targets the class C Vps complex to coordinate autophagosome maturation and endocytic trafficking , 2008, Nature Cell Biology.

[24]  Daniel J. Klionsky,et al.  Autophagy fights disease through cellular self-digestion , 2008, Nature.

[25]  D. Klionsky,et al.  Autophagosome formation: core machinery and adaptations , 2007, Nature Cell Biology.

[26]  J. J. Mul,et al.  Bif-1 interacts with Beclin 1 through UVRAG and regulates autophagy and tumorigenesis , 2007, Nature Cell Biology.

[27]  E. White,et al.  Autophagy mitigates metabolic stress and genome damage in mammary tumorigenesis. , 2007, Genes & development.

[28]  E. White,et al.  Autophagy suppresses tumor progression by limiting chromosomal instability. , 2007, Genes & development.

[29]  G. Evan,et al.  Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma. , 2007, The Journal of clinical investigation.

[30]  Jung Young Lee,et al.  Decreased expression of tumour suppressor Bax‐interacting factor‐1 (Bif‐1), a Bax activator, in gastric carcinomas , 2006, Pathology.

[31]  Kevin Bray,et al.  Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis. , 2006, Cancer cell.

[32]  B. Oh,et al.  Autophagic and tumour suppressor activity of a novel Beclin1-binding protein UVRAG , 2006, Nature Cell Biology.

[33]  Jie Wu,et al.  Loss of Bif-1 Suppresses Bax/Bak Conformational Change and Mitochondrial Apoptosis , 2005, Molecular and Cellular Biology.

[34]  R. Youle,et al.  Endophilin B1 is required for the maintenance of mitochondrial morphology , 2004, The Journal of cell biology.

[35]  T. Umata,et al.  c-myc induces autophagy in rat 3Y1 fibroblast cells. , 2003, Cell structure and function.

[36]  S. Korsmeyer,et al.  Bax Loss Impairs Myc-Induced Apoptosis and Circumvents the Selection of p53 Mutations during Myc-Mediated Lymphomagenesis , 2001, Molecular and Cellular Biology.

[37]  M. Roussel,et al.  Apoptosis Triggered by Myc-Induced Suppression of Bcl-XL or Bcl-2 Is Bypassed during Lymphomagenesis , 2001, Molecular and Cellular Biology.

[38]  Sujay K. Singh,et al.  Molecular Cloning and Characterization of Bif-1 , 2001, The Journal of Biological Chemistry.

[39]  M. Roussel,et al.  Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis. , 1999, Genes & development.

[40]  K Autio,et al.  DNA copy number losses in human neoplasms. , 1999, The American journal of pathology.

[41]  A. W. Harris,et al.  The E mu-myc transgenic mouse. A model for high-incidence spontaneous lymphoma and leukemia of early B cells , 1988, The Journal of experimental medicine.

[42]  A. W. Harris,et al.  The c-myc oncogene perturbs B lymphocyte development in Eμ-myc transgenic mice , 1986, Cell.

[43]  M. Roizen,et al.  Hallmarks of Cancer: The Next Generation , 2012 .

[44]  R. Youle,et al.  Mechanisms of mitophagy , 2010, Nature Reviews Molecular Cell Biology.

[45]  E. Morselli,et al.  Control of autophagy by oncogenes and tumor suppressor genes , 2009, Cell Death and Differentiation.